ROMA™ (Risk of Ovarian Malignancy Algorithm)
Test Code
Clinical Significance
ROMA™ (Risk of Ovarian Malignancy Algorithm) - The risk of Ovarian Malignancy Algorithm (ROMA™) test is intended to aid in assessing the risk of ovarian cancer in women with a pelvic mass based on the patient's HE4 and CA125 levels, and their menopausal status. Women with ROMA™ levels above the cutoff have an increased risk of ovarian cancer. ROMA™ must be interpreted in conjunction with an independent clinical and radiological assessment.
The ROMA™ test is indicated for women who meet the following criteria:
over age 18; presence of an ovarian pelvic mass for which surgery is planned; and not yet ...
Test Resources
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Methodology
Reference Range(s)
| ROMA Premenopausal | <1.31 |
| ROMA Postmenopausal | <2.77 |
| CA125 | <35 U/mL |
| HE4, Ovarian CA Monitoring | |
| Female Premenopausal | ≤70 pmol/L |
| Female Postmenopausal | ≤140 pmol/L |
Preferred Specimen(s)
1 mL serum
Minimum Volume
0.5 mL
Collection Instructions
Sample collected in red-top tube must be allowed to clot for at least 30 minutes but no longer than 1 hour.
Transport Container
Transport tube
Transport Temperature
Frozen
Specimen Stability
- Room temperature: 24 hours
- Refrigerated: 72 hours
- Frozen: 28 days
Reject Criteria
Moderate to gross hemolysis • Lipemia • Icteric specimens • Presence of fibrin • Red blood cells • Other particulate matter • Obvious microbial contamination
Setup Schedule
Refrigerated: 72 hours
Frozen: 28 days